{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:28:16Z","timestamp":1792528096487,"version":"4.5.0"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002811","name":"Cathay General Hospital","doi-asserted-by":"publisher","award":["CGH-MR-A113009"],"award-info":[{"award-number":["CGH-MR-A113009"]}],"id":[{"id":"10.13039\/501100002811","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002811","name":"Cathay General Hospital","doi-asserted-by":"publisher","award":["CGH-MR-B113012"],"award-info":[{"award-number":["CGH-MR-B113012"]}],"id":[{"id":"10.13039\/501100002811","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002811","name":"Cathay General Hospital","doi-asserted-by":"publisher","award":["CGH-MR-A113016"],"award-info":[{"award-number":["CGH-MR-A113016"]}],"id":[{"id":"10.13039\/501100002811","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.biopha.2025.118508","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T13:58:39Z","timestamp":1756475919000},"page":"118508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Transcriptional dysregulation of skin barrier genes in atopic dermatitis and psoriasis: Mechanistic insights and emerging therapeutic strategies"],"prefix":"10.1016","volume":"191","author":[{"given":"Yang","family":"Che-Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Che","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6337-4817","authenticated-orcid":false,"given":"Jiun-Wen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2025.118508_bib1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000534136","article-title":"The skin barrier and moisturization: function, disruption, and mechanisms of repair","volume":"36","author":"Rajkumar","year":"2023","journal-title":"Ski. Pharm. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118508_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1473-2165.2007.00300.x","article-title":"Skin hydration: a review on its molecular mechanisms","volume":"6","author":"Verdier-Sevrain","year":"2007","journal-title":"J. Cosmet. Dermatol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118508_bib3","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41590-018-0256-2","article-title":"The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis","volume":"19","author":"Dainichi","year":"2018","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118508_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/imm.13152","article-title":"Skin barrier immunity and ageing","volume":"160","author":"Chambers","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.biopha.2025.118508_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cytogfr.2019.08.001","article-title":"Architecture of antimicrobial skin defense","volume":"49","author":"Kwiecien","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.biopha.2025.118508_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1239251","article-title":"\"Outside-to-inside,\" \"inside-to-outside,\" and \"intrinsic\" endogenous pathogenic mechanisms in atopic dermatitis: keratinocytes as the key functional cells involved in both permeability barrier dysfunction and immunological alterations","volume":"14","author":"Hatano","year":"2023","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118508_bib7","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/iid3.427","article-title":"IL-13 modulates \u2206Np63 levels causing altered expression of barrier- and inflammation-related molecules in human keratinocytes: a possible explanation for chronicity of atopic dermatitis","volume":"9","author":"Kubo","year":"2021","journal-title":"Immun. Inflamm. Dis."},{"issue":"15","key":"10.1016\/j.biopha.2025.118508_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155382","article-title":"Regulation of filaggrin, loricrin, and involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: pathogenic implications in atopic dermatitis","volume":"21","author":"Furue","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2025.118508_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/imm.13120","article-title":"The IL-13-OVOL1-FLG axis in atopic dermatitis","volume":"158","author":"Furue","year":"2019","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.biopha.2025.118508_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2019.08.006","article-title":"Interleukin-33 in atopic dermatitis","volume":"96","author":"Imai","year":"2019","journal-title":"J. Dermatol. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2025.118508_bib11","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1016\/j.ajpath.2015.06.021","article-title":"Diverse regulation of claudin-1 and claudin-4 in atopic dermatitis","volume":"185","author":"Gruber","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118508_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/2589977513666210707114520","article-title":"IL-23\/Th17 axis: a potential therapeutic target of psoriasis","volume":"14","author":"Sharma","year":"2022","journal-title":"Curr. Drug Res Rev."},{"issue":"10281","key":"10.1016\/j.biopha.2025.118508_bib13","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.biopha.2025.118508_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080807","article-title":"Keratin 6, 16 and 17-critical barrier alarmin molecules in skin wounds and psoriasis","volume":"8","author":"Zhang","year":"2019","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.biopha.2025.118508_bib15","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nrm1619","article-title":"The cornified envelope: a model of cell death in the skin","volume":"6","author":"Candi","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118508_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000441539","article-title":"Filaggrin and skin barrier function","volume":"49","author":"Kezic","year":"2016","journal-title":"Curr. Probl. Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118508_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12272-021-01305-x","article-title":"Skin barrier dysfunction and filaggrin","volume":"44","author":"Kim","year":"2021","journal-title":"Arch. Pharm. Res"},{"issue":"9","key":"10.1016\/j.biopha.2025.118508_bib18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1600-0625.2012.01472.x","article-title":"The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the 'fused genes' family","volume":"21","author":"Kypriotou","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.biopha.2025.118508_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.12688\/wellcomeopenres.15729.2","article-title":"Changes in nano-mechanical properties of human epidermal cornified cells in children with atopic dermatitis","volume":"5","author":"Haftek","year":"2020","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.biopha.2025.118508_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/1523-1747.ep12540777","article-title":"Biochemistry of transglutaminases and cross-linking in the skin","volume":"81","author":"Peterson","year":"1983","journal-title":"J. Invest Dermatol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118508_bib21","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1365-2133.2012.10885.x","article-title":"Expression profile of cornified envelope structural proteins and keratinocyte differentiation-regulating proteins during skin barrier repair","volume":"166","author":"de Koning","year":"2012","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118508_bib22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1523-1747.1998.00318.x","article-title":"Expression of epidermal keratins and the cornified envelope protein involucrin is influenced by permeability barrier disruption","volume":"111","author":"Ekanayake-Mudiyanselage","year":"1998","journal-title":"J. Invest Dermatol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118508_bib23","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.jid.2017.05.015","article-title":"Nrf2 promotes keratinocyte proliferation in psoriasis through Up-Regulation of keratin 6, keratin 16, and keratin 17","volume":"137","author":"Yang","year":"2017","journal-title":"J. Invest Dermatol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118508_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.108805","article-title":"Significance of stress keratin expression in normal and diseased epithelia","volume":"27","author":"Cohen","year":"2024","journal-title":"iScience"},{"issue":"7","key":"10.1016\/j.biopha.2025.118508_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.322","article-title":"Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis","volume":"8","author":"Tsuji","year":"2017","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.biopha.2025.118508_bib26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00403-024-03268-7","article-title":"Benvitimod upregulates filaggrin, involucrin and loricrin expressions via aryl hydrocarbon receptor-OVO-like 1 axis","volume":"316","author":"Jia","year":"2024","journal-title":"Arch. Dermatol. Res"},{"issue":"5","key":"10.1016\/j.biopha.2025.118508_bib27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4103\/idoj.idoj_636_22","article-title":"Genotype study of filaggrin gene Loss-of-Function mutations in central India population with atopic dermatitis and ichthyosis vulgaris","volume":"14","author":"Chawla","year":"2023","journal-title":"Indian Dermatol. Online J."},{"key":"10.1016\/j.biopha.2025.118508_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148397","article-title":"Association between polymorphisms and atopic dermatitis susceptibility: a systematic review and meta-analysis","volume":"913","author":"Huang","year":"2024","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.biopha.2025.118508_bib29","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1111\/1346-8138.15736","article-title":"Filaggrin gene (FLG) promoter polymorphisms are associated with atopic dermatitis in the Japanese population","volume":"48","author":"Teye","year":"2021","journal-title":"J. Dermatol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118508_bib30","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jaci.2021.07.003","article-title":"Novel role for caspase recruitment domain family member 14 and its genetic variant rs11652075 in skin filaggrin homeostasis","volume":"149","author":"DeVore","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118508_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.18176\/jiaci.0978","article-title":"A deep intronic polymorphism at 9q21.11 contributes to the risk of atopic dermatitis through Methylation-Regulated expression of tight junction protein 2","volume":"35","author":"Lim","year":"2025","journal-title":"J. Invest. Allergol. Clin. Immunol."},{"key":"10.1016\/j.biopha.2025.118508_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.927465","article-title":"Claudin-1 mediated tight junction dysfunction as a contributor to atopic March","volume":"13","author":"Xia","year":"2022","journal-title":"Front Immunol."},{"issue":"28","key":"10.1016\/j.biopha.2025.118508_bib33","article-title":"Genetic polymorphisms in serine protease inhibitor Kazal-type 5 and risk of atopic dermatitis: a meta-analysis","volume":"99","author":"Li","year":"2020","journal-title":"Med. (Baltim. )"},{"issue":"6","key":"10.1016\/j.biopha.2025.118508_bib34","doi-asserted-by":"crossref","first-page":"538","DOI":"10.5021\/ad.2020.32.6.538","article-title":"Corrigendum: association of DOCK8, IL17RA, and KLK12 polymorphisms with atopic dermatitis in Koreans","volume":"32","author":"Heo","year":"2020","journal-title":"Ann. Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118508_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/25785826.2022.2132683","article-title":"Association of TLR2 and TLR9 gene polymorphisms with atopic dermatitis: a systematic review and meta-analysis with trial sequential analysis","volume":"46","author":"Zhou","year":"2023","journal-title":"Immunol. Med"},{"issue":"5","key":"10.1016\/j.biopha.2025.118508_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24385","article-title":"TLR4 polymorphisms as potential predictors of atopic dermatitis in Chinese han children","volume":"36","author":"Shi","year":"2022","journal-title":"J. Clin. Lab Anal."},{"key":"10.1016\/j.biopha.2025.118508_bib37","article-title":"Association between IL-6 polymorphisms and atopic dermatitis in Chinese han children","volume":"11","author":"Huang","year":"2023","journal-title":"Front Pedia"},{"issue":"4","key":"10.1016\/j.biopha.2025.118508_bib38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.5114\/ada.2024.141783","article-title":"Association between single nucleotide polymorphisms of interleukin-35 genes and atopic dermatitis","volume":"41","author":"Zysk","year":"2024","journal-title":"Post. Dermatol. Alergol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118508_bib39","article-title":"Associations between interleukin-13, interleukin-4 and their receptor gene polymorphisms and susceptibility to atopic dermatitis in a Chinese han population","volume":"90","author":"Zhong","year":"2024","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118508_bib40","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1038\/jid.2012.167","article-title":"Genetics of psoriasis: evidence for epistatic interaction between skin barrier abnormalities and immune deviation","volume":"132","author":"Bergboer","year":"2012","journal-title":"J. Invest Dermatol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118508_bib41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00403-007-0821-2","article-title":"Association between P478S polymorphism of the filaggrin gene and risk of psoriasis in a Chinese population in Taiwan","volume":"300","author":"Chang","year":"2008","journal-title":"Arch. Dermatol. Res."},{"issue":"3","key":"10.1016\/j.biopha.2025.118508_bib42","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/jid.2008.273","article-title":"Association of skin barrier genes within the PSORS4 locus is enriched in Singaporean Chinese with early-onset psoriasis","volume":"129","author":"Chen","year":"2009","journal-title":"J. Invest Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118508_bib43","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1038\/s41598-023-30464-8","article-title":"Influence of aldo-keto reductase 1C3 polymorphisms in early-onset female psoriasis patients","volume":"13","author":"Nojiri","year":"2023","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.biopha.2025.118508_bib44","first-page":"3599","article-title":"ZEB2-transgene expression in the epidermis compromises the integrity of the epidermal barrier through the repression of different tight junction proteins","volume":"71","author":"Tatari","year":"2014","journal-title":"Cell Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118508_bib45","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1083\/jcb.200110122","article-title":"Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice","volume":"156","author":"Furuse","year":"2002","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118508_bib46","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2133.2006.07642.x","article-title":"Tight junction components occludin, ZO-1, and claudin-1, -4 and -5 in active and healing psoriasis","volume":"156","author":"Peltonen","year":"2007","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118508_bib47","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jdermsci.2012.11.595","article-title":"Impaired tight junctions obstruct stratum corneum formation by altering polar lipid and profilaggrin processing","volume":"69","author":"Yuki","year":"2013","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118508_bib48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jdermsci.2013.01.002","article-title":"Tight junction dysfunction in the stratum granulosum leads to aberrant stratum corneum barrier function in claudin-1-deficient mice","volume":"70","author":"Sugawara","year":"2013","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118508_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kjms.2012.08.001","article-title":"New insights into desmosome regulation and pemphigus blistering as a desmosome-remodeling disease","volume":"29","author":"Kitajima","year":"2013","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"40","key":"10.1016\/j.biopha.2025.118508_bib50","doi-asserted-by":"crossref","first-page":"15405","DOI":"10.1073\/pnas.0807374105","article-title":"New insights into cadherin function in epidermal sheet formation and maintenance of tissue integrity","volume":"105","author":"Tinkle","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.biopha.2025.118508_bib51","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s40257-021-00619-2","article-title":"Ceramides in skin health and disease: an update","volume":"22","author":"Uchida","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.biopha.2025.118508_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101264","article-title":"The heterogeneity and complexity of skin surface lipids in human skin health and disease","volume":"93","author":"Mijaljica","year":"2024","journal-title":"Prog. Lipid Res"},{"issue":"3","key":"10.1016\/j.biopha.2025.118508_bib53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.bbalip.2013.08.009","article-title":"The roles of ABCA12 in epidermal lipid barrier formation and keratinocyte differentiation","volume":"1841","author":"Akiyama","year":"2014","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.biopha.2025.118508_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2025.1387128","article-title":"Effects of Th1\/Th17 and Th2 cytokines on lipid metabolism in differentiated keratinocytes","volume":"16","author":"Cavallo","year":"2025","journal-title":"Front Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118508_bib55","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.jid.5700640","article-title":"Novel mutations in ALOX12B in patients with autosomal recessive congenital ichthyosis and evidence for genetic heterogeneity on chromosome 17p13","volume":"127","author":"Lesueur","year":"2007","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118508_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13020291","article-title":"Abnormalities of sphingolipids metabolic pathways in the pathogenesis of psoriasis","volume":"13","author":"Burger","year":"2023","journal-title":"Metabolites"},{"issue":"18","key":"10.1016\/j.biopha.2025.118508_bib57","doi-asserted-by":"crossref","first-page":"13211","DOI":"10.1074\/jbc.M611562200","article-title":"Fatty acid 2-hydroxylase, encoded by FA2H, accounts for differentiation-associated increase in 2-OH ceramides during keratinocyte differentiation","volume":"282","author":"Uchida","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2025.118508_bib58","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jid.2022.07.024","article-title":"Association of early clinical response to laser rejuvenation of photoaged skin with increased lipid metabolism and restoration of skin barrier function","volume":"143","author":"Garza","year":"2023","journal-title":"J. Invest. Dermatol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118508_bib59","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/hmg\/ddx079","article-title":"PNPLA1 defects in patients with autosomal recessive congenital ichthyosis and KO mice sustain PNPLA1 irreplaceable function in epidermal omega-O-acylceramide synthesis and skin permeability barrier","volume":"26","author":"Pichery","year":"2017","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"10.1016\/j.biopha.2025.118508_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112506","article-title":"New treatments for atopic dermatitis targeting skin barrier repair via the regulation of FLG expression","volume":"10","author":"Debinska","year":"2021","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.biopha.2025.118508_bib61","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00075.2020","article-title":"Aquaporin-3 in the epidermis: more than skin deep","volume":"318","author":"Bollag","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118508_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23074020","article-title":"Aquaporins are one of the critical factors in the disruption of the skin barrier in inflammatory skin diseases","volume":"23","author":"Tricarico","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2025.118508_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/biology13110862","article-title":"Aquaporin channels in skin physiology and aging pathophysiology: investigating their role in skin function and the hallmarks of aging","volume":"13","author":"Karimi","year":"2024","journal-title":"Biology"},{"issue":"9","key":"10.1016\/j.biopha.2025.118508_bib64","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1398-9995.2006.01151.x","article-title":"Increased expression of aquaporin 3 in atopic eczema","volume":"61","author":"Olsson","year":"2006","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.biopha.2025.118508_bib65","article-title":"Physiological, pathological, and circadian factors impacting skin hydration","volume":"14","author":"Camilion","year":"2022","journal-title":"Cureus"},{"issue":"675","key":"10.1016\/j.biopha.2025.118508_bib66","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abp9159","article-title":"Dual antibody inhibition of KLK5 and KLK7 for netherton syndrome and atopic dermatitis","volume":"14","author":"Chavarria-Smith","year":"2022","journal-title":"Sci. Transl. Med"},{"issue":"12","key":"10.1016\/j.biopha.2025.118508_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/medicina57121387","article-title":"Topical application of Galgeunhwanggeumhwangryeon-Tang recovers Skin-Lipid barrier and ameliorates inflammation via Filaggrin-Thymic stromal Lymphopoietin-Interleukin 4 pathway","volume":"57","author":"Ahn","year":"2021","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.biopha.2025.118508_bib68","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/bjd\/ljad332","article-title":"Retrospective pharmacogenetic study of psoriasis highlights the role of KLK7 in tumour necrosis factor signalling","volume":"190","author":"Zhang","year":"2023","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118508_bib69","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1365-2133.2009.09273.x","article-title":"Significant upregulation of antimicrobial peptides and proteins in lichen sclerosus","volume":"161","author":"Gambichler","year":"2009","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118508_bib70","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/jid.2008.268","article-title":"The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption","volume":"129","author":"Glaser","year":"2009","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118508_bib71","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4049\/jimmunol.181.2.1499","article-title":"Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15","volume":"181","author":"Wolf","year":"2008","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118508_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1390","article-title":"Molecular and cellular mechanisms of itch and pain in atopic dermatitis and implications for novel therapeutics","volume":"11","author":"Kwatra","year":"2022","journal-title":"Clin. Transl. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118508_bib73","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/jid.2010.344","article-title":"IL-1alpha stimulation restores epidermal permeability and antimicrobial barriers compromised by topical tacrolimus","volume":"131","author":"Jung","year":"2011","journal-title":"J. Invest Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118508_bib74","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2133.2008.08643.x","article-title":"Glycerol and the skin: holistic approach to its origin and functions","volume":"159","author":"Fluhr","year":"2008","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118508_bib75","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s13555-020-00482-9","article-title":"Calcipotriol\/Betamethasone dipropionate foam inhibits Th17 cytokine secretion and improves epidermal barrier markers in a human Th17 skin inflammation model","volume":"11","author":"Lovato","year":"2021","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.biopha.2025.118508_bib76","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/978-1-4939-9030-6_45","article-title":"S100A7 in psoriasis: immunodetection and activation by CRISPR technology","volume":"1929","author":"Granata","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118508_bib77","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/exd.13182","article-title":"IL-17F regulates psoriasis-associated genes through IkappaBzeta","volume":"26","author":"Bertelsen","year":"2017","journal-title":"Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118508_bib78","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s13555-021-00611-y","article-title":"Urea in dermatology: a review of its emollient, moisturizing, keratolytic, skin barrier enhancing and antimicrobial properties","volume":"11","author":"Piquero-Casals","year":"2021","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.biopha.2025.118508_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105538","article-title":"Baicalin ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice through modulating skin barrier function, gut microbiota and JAK\/STAT pathway","volume":"119","author":"Wang","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2025.118508_bib80","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jid.2018.12.018","article-title":"Atopic dermatitis is an IL-13-Dominant disease with greater molecular heterogeneity compared to psoriasis","volume":"139","author":"Tsoi","year":"2019","journal-title":"J. Invest Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118508_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2018.10.032","article-title":"Atopic dermatitis endotypes and implications for targeted therapeutics","volume":"143","author":"Czarnowicki","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118508_bib82","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.jid.2020.12.031","article-title":"Assay for Transposase-Accessible chromatin using sequencing analysis reveals a widespread increase in chromatin accessibility in psoriasis","volume":"141","author":"Tang","year":"2021","journal-title":"J. Invest Dermatol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118508_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25105375","article-title":"Recent advances in Phytochemical-Based topical applications for the management of eczema: a review","volume":"25","author":"Radhakrishnan","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118508_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111741","article-title":"A comprehensive review of natural products against atopic dermatitis: flavonoids, alkaloids, terpenes, glycosides and other compounds","volume":"140","author":"Wu","year":"2021","journal-title":"Biomed. Pharm."},{"issue":"21","key":"10.1016\/j.biopha.2025.118508_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215424","article-title":"Aryl hydrocarbon receptor in atopic dermatitis and psoriasis","volume":"20","author":"Furue","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118508_bib86","article-title":"Tapinarof cream 1% once daily for the treatment of adults with mild to severe plaque psoriasis: a novel topical therapy targeting the aryl hydrocarbon receptor","volume":"29","author":"Armstrong","year":"2023","journal-title":"J. Manag Care Spec. Pharm."},{"key":"10.1016\/j.biopha.2025.118508_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114492","article-title":"Amelioration of imiquimod induced psoriasis through reduction in IL-17A and Th17 population by dihydromyricetin involves regulation of RORgammat pathway","volume":"153","author":"Sarkar","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118508_bib88","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10787-023-01178-0","article-title":"Review of natural compounds for potential psoriasis treatment","volume":"31","author":"Elkhawaga","year":"2023","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2025.118508_bib89","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s12906-017-1947-1","article-title":"Clinical efficacy and IL-17 targeting mechanism of indigo naturalis as a topical agent in moderate psoriasis","volume":"17","author":"Cheng","year":"2017","journal-title":"BMC Complement Alter. Med."},{"issue":"3","key":"10.1016\/j.biopha.2025.118508_bib90","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jdermsci.2009.02.007","article-title":"Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active component","volume":"54","author":"Lin","year":"2009","journal-title":"J. Dermatol. Sci."},{"issue":"24","key":"10.1016\/j.biopha.2025.118508_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29245951","article-title":"Natural products as modulators of aryl hydrocarbon receptor signaling in atopic dermatitis management","volume":"29","author":"Lee","year":"2024","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.biopha.2025.118508_bib92","article-title":"l-Histidine supplementation in adults and young children with atopic dermatitis (Eczema)","volume":"150","author":"Gibbs","year":"2020","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2025.118508_bib93","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/CCID.S146760","article-title":"Feeding filaggrin: effects of l-histidine supplementation in atopic dermatitis","volume":"10","author":"Tan","year":"2017","journal-title":"Clin. Cosmet. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118508_bib94","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40257-017-0301-1","article-title":"Natural oils for skin-barrier repair: ancient compounds now backed by modern science","volume":"19","author":"Vaughn","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.biopha.2025.118508_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155856","article-title":"Targeting mitochondrial dysfunction in atopic dermatitis with trilinolein: a triacylglycerol from the medicinal plant cannabis fructus","volume":"132","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.biopha.2025.118508_bib96","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.jid.2017.05.004","article-title":"Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans","volume":"137","author":"Smith","year":"2017","journal-title":"J. Invest Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118508_bib97","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","article-title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","volume":"143","author":"Guttman-Yassky","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.biopha.2025.118508_bib98","article-title":"Tralokinumab treatment of atopic dermatitis induces a progressive transcriptomic response","author":"Tandon","year":"2024","journal-title":"J. Invest Dermatol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118508_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2022.100131","article-title":"Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis","volume":"2","author":"Beck","year":"2022","journal-title":"JID Innov."},{"issue":"7","key":"10.1016\/j.biopha.2025.118508_bib100","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.jid.2022.12.012","article-title":"Baricitinib blocks Cytokine-Mediated downregulation of PAD1 in human keratinocytes: a possible molecular link to the effects of JAK inhibitors in atopic dermatitis","volume":"143","author":"Padhi","year":"2023","journal-title":"J. Invest Dermatol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118508_bib101","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10528-020-10003-0","article-title":"CYT387, a novel JAK2 inhibitor, suppresses IL-13-Induced epidermal barrier dysfunction via miR-143 targeting IL-13Ralpha1 and STAT3","volume":"59","author":"Zu","year":"2021","journal-title":"Biochem Genet"},{"issue":"10","key":"10.1016\/j.biopha.2025.118508_bib102","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1080\/13543784.2020.1800639","article-title":"Baricitinib: therapeutic potential for moderate to severe atopic dermatitis","volume":"29","author":"Calabrese","year":"2020","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"5","key":"10.1016\/j.biopha.2025.118508_bib103","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/ced.14567","article-title":"Janus kinase inhibitors for atopic dermatitis: a promising treatment modality","volume":"46","author":"Cartron","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118508_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/medicina60081376","article-title":"Restoration of skin barrier abnormalities with IL4\/13 inhibitors and jak inhibitors in atopic dermatitis: a systematic review","volume":"60","author":"Chatzigeorgiou","year":"2024","journal-title":"Medicina"},{"key":"10.1016\/j.biopha.2025.118508_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1473356","article-title":"Effectiveness, quality of life, and safety of secukinumab versus conventional systemic therapy in patients with erythrodermic psoriasis: a comparative study","volume":"11","author":"Zhou","year":"2024","journal-title":"Front Med."},{"issue":"3","key":"10.1016\/j.biopha.2025.118508_bib106","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jaci.2019.04.029","article-title":"IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis","volume":"144","author":"Krueger","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118508_bib107","article-title":"Bimekizumab for the treatment of plaque psoriasis with involvement of genitalia: a 16-Week multicenter Real-World experience - IL PSO (Italian Landscape Psoriasis)","volume":"14","author":"Orsini","year":"2024","journal-title":"Dermatol. Pr. Concept"},{"issue":"10273","key":"10.1016\/j.biopha.2025.118508_bib108","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(21)00125-2","article-title":"Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial","volume":"397","author":"Reich","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2025.118508_bib109","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/s00403-025-04168-0","article-title":"The role of LINC00114 in atopic dermatitis: modulating inflammation and epidermal barrier dysfunction","volume":"317","author":"Sun","year":"2025","journal-title":"Arch. Dermatol. Res."},{"issue":"3","key":"10.1016\/j.biopha.2025.118508_bib110","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaci.2020.02.007","article-title":"Belinostat resolves skin barrier defects in atopic dermatitis by targeting the dysregulated miR-335:SOX6 axis","volume":"146","author":"Liew","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118508_bib111","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5021\/ad.2020.32.2.122","article-title":"Epigenetic regulation of filaggrin gene expression in human epidermal keratinocytes","volume":"32","author":"Lee","year":"2020","journal-title":"Ann. Dermatol."},{"key":"10.1016\/j.biopha.2025.118508_bib112","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbrc.2021.10.057","article-title":"Impact of chlorogenic acid on modulation of significant genes in dermal fibroblasts and epidermal keratinocytes","volume":"583","author":"Lee","year":"2021","journal-title":"Biochem. Biophys. Res Commun."},{"issue":"9","key":"10.1016\/j.biopha.2025.118508_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/nu13093209","article-title":"Lithospermum erythrorhizon alleviates atopic Dermatitis-like skin lesions by restoring immune balance and skin barrier function in 2.4-Dinitrochlorobenzene-Induced NC\/Nga mice","volume":"13","author":"Oh","year":"2021","journal-title":"Nutrients"},{"issue":"14","key":"10.1016\/j.biopha.2025.118508_bib114","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400054RR","article-title":"Postbiotic lactobacilli induce cutaneous antimicrobial response and restore the barrier to inhibit the intracellular invasion of staphylococcus aureus in vitro and ex vivo","volume":"38","author":"Dinic","year":"2024","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.biopha.2025.118508_bib115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jdv.16516","article-title":"Protective effect of aquaphilus dolomiae extract-G1, ADE-G1, on tight junction barrier function in a staphylococcus aureus-infected atopic dermatitis model","volume":"34","author":"Galliano","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118508_bib116","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/bjd.19431","article-title":"Machine learning applied to atopic dermatitis transcriptome reveals distinct therapy-dependent modification of the keratinocyte immunophenotype","volume":"184","author":"Clayton","year":"2021","journal-title":"Br. J. Dermatol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:54:33Z","timestamp":1772819673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225007024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":116,"alternative-id":["S0753332225007024"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118508","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptional dysregulation of skin barrier genes in atopic dermatitis and psoriasis: Mechanistic insights and emerging therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118508"}}